Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor com...
Amylyx Pharmaceuticals Logo
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops a proprietary therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Amylyx Pharmaceuticals serves customers worldwide.
Address
43 Thorndike Street,
Cambridge, 02141
United States
Year founded
2014
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
